Clinical Trial Update: Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma

View source ↗

Summary

This completed observational study evaluates the efficacy and safety of the VMP regimen (bortezomib, melphalan, prednisone) in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Multiple Myeloma | Status: COMPLETED